TIDES GROUP, LLC

Lobbying for SIGA TECHNOLOGIES, INC. · biodefense countermeasure pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $140,000.00 income · posted Jan 19, 2026

Lobbying activity 3

Budget/Appropriations

Issues related to biodefense countermeasures, strategic national stockpile, pandemic response.

Defense

Issues related to biodefense countermeasures, strategic national stockpile, pandemic response.

Health Issues

Issues related to biodefense countermeasures, strategic national stockpile, pandemic response.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.